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Abstract Osteoporosis (OP) and osteoporotic fracture are
major public health issues for society; the burden for the af-
fected individual is also high. Previous studies have shown
that pulsed wave low-level laser therapy (PW LLLT) has os-
teogenic effects. This study intended to evaluate the impacts
of PW LLLTon the cortical bone of osteoporotic rats’ tibias in
two experimental models, ovariectomized and dexametha-
sone-treated. We divided the rats into four ovariectomized
induced OP (OVX-d) and four dexamethasone-treated
(glucocorticoid-induced OP, GIOP) groups. A healthy (H)
group of rats was considered for baseline evaluations. At
14 weeks following ovariectomy, we subdivided the OVX-d
rats into the following groups: (i) control which had OP, (ii)
OVX-d rats treated with alendronate (1 mg/kg), (iii) OVX-d
rats treated with LLLT, and (iv) OVX-d rats treated with
alendronate and PW LLLT. The remaining rats received dexa-
methasone over a 5-week period and were also subdivided
into four groups: (i) control rats treated with intramuscular
(i.m.) injections of distilled water (vehicle), (ii) rats treated
with subcutaneous alendronate injections (1 mg/kg), (iii)
laser-treated rats, and (iv) rats simultaneously treated with
laser and alendronate. The rats received alendronate for
30 days and underwent PW LLLT (890 nm, 80 Hz, 0.972 J/
cm2) three times per week during 8 weeks. Then, the right
tibias were extracted and underwent a stereological analysis
of histological parameters and real-time polymerase chain re-
action (RT-PCR). A significant increase in cortical bone vol-
ume (mm3) existed in all study groups compared to the
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healthy rats. There were significant decreases in trabecular
bone volume (mm3) in all study groups compared to the group
of healthy rats. The control rats with OP and rats from the
vehicle group showed significantly increased osteoclast num-
bers compared tomost other groups. Alendronate significantly
decreased osteoclast numbers in osteoporotic rats. Concurrent
treatments (compounded by PW LLLT and alendronate) pro-
duce the same effect on osteoporotic bone.
Keywords Osteoporosis . Glucocorticoid-induced
osteoporosis . Low-level laser therapy . Ovariectomized
induced osteoporosis . Biomechanical properties .
Stereology . Real-time polymerase chain reaction
Abbreviations
OP Osteoporosis
BMU Basic multicellular unit
ECM Extracellular matrix
TGF-β Transforming growth factor beta
IGF-I Insulin-like growth factor-I
BMPs Bone morphogenetic proteins
GC Glucocorticoid
GIOP Glucocorticoid-induced osteoporosis
BMD Bone mineral density
LLLT Low-level laser therapy
LED Light-emitting diode of Sohn et al. [15] study
CW Continuous wave
PW Pulsed wave
OVX-d Ovariectomized induced OP
RT-PCR Real-time polymerase chain reaction
cDNA Complementary DNA
LSD Least significant difference
GTP Guanosine triphosphate
AlGaAs Aluminum gallium arsenide
Introduction
Osteoporosis (OP), a common bone disease is characterized
by reductions in bone density and deterioration of bone struc-
ture [1]. Osteoporosis and osteoporotic fracture are major pub-
lic health issues for society; the burden for the affected indi-
vidual is also high [2], potentially leading to bone fractures
and their resultant complications. The most common fractures
are those of the vertebrae, proximal femur (femoral neck), and
distal forearm (wrist) [3]. Hip fractures impose an excess an-
nual mortality rate of 8 to 36 % [4]. Postmenopausal estrogen
deficiency is the cause of OP type I, which is the most prev-
alent form of the disease [5]. The reduction in bone mass that
occurs during estrogen deficiency has long been regarded as
the critical event leading to bone fracture.
Microarchitecture describes the microscopic structure and
morphology of trabecular and cortical bones. It is character-
ized using bone histomorphometry and micro-CT scanning
(μCT). Osteoporotic fractures are believed to occur when both
the bone mass and the microarchitecture of the bone degrade
to such an extent that bone strength is reduced. These fractures
occur under normal physiological loads [6]. Evidence sug-
gests that estrogen-deficient states lead to increased
microdamage [7]. Osteoblasts and osteoclasts, together re-
ferred to as the basic multicellular unit (BMU), regulate bone
remodeling. Having estrogen receptors, osteoclasts trigger
protein synthesis when activated by estrogen [8]. Estrogen
has an inhibitory effect on osteoclasts as the proteins produced
following estrogen binding inhibit bone resorption by decreas-
ing the formation of mature osteoclasts [8] and increasing
osteoclast apoptosis [9]. When estrogen levels are deficient,
the number of hematopoietic progenitors increases. Because
they possess estrogen receptors [8], the normal function of
osteoblasts and osteocytes is affected during estrogen-
deficient states such as during the post-menopausal period.
A number of cytokines and growth factors govern the ac-
tivity of bone cells during normal bone remodeling. The ex-
tracellular matrix (ECM) releases factors such as transforming
growth factor beta (TGF-β) and insulin-like growth factor-I
(IGF-I) during bone resorption. These factors recruit and ac-
tivate osteoblasts to begin collagen synthesis. Collagen type 1
is involved in skeletal development and has regulatory effects
on bone cells [10]. The process of osteoblast maturation is
affected by the action of various endocrine, paracrine, and
autocrine factors. These factors include a number of bone
morphogenetic proteins (BMPs) and IGF-I. Medically admin-
istered to facilitate spinal fusion, the recombinant human
BMP-2 is approved for OP therapy [11].
Glucocorticoid (GC)-induced osteoporosis (GIOP) is the
most common cause of secondary OP [12]. Bisphosphonates
are f irs t- l ine prophylact ic agents for GIOP. The
bisphosphonates, alendronate and risedronate, both increase
the bone mineral density (BMD) of the spine and hips and
reduce the vertebral fracture rate [13]. Treatment with anabol-
ic agents such as low-level lasers strongly stimulates bone
turnover and seems to be superior to treatment with
alendronate [12, 13].
Prevention of OP and its complications is an essential so-
cioeconomic priority [14]. Numerous treatments exist and in-
clude estrogen therapy, bisphosphonate compounds, physical
activity programs, and low-level laser therapy (LLLT).
One study showed that light-emitting diode (LED) irra-
diation downregulated osteoclastogenesis by reducing
ROS production. The authors concluded that LED irradia-
tion or LLLT might be useful as an alternative, conserva-
tive approach to OP management [15]. Kiyosaki et al. re-
ported that continuous wave (CW) LLLT increased the
production of IGF-I and BMP, which stimulated bone
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mineralization [16] and significantly stimulated the num-
ber and area of bone nodules [17].
The benefits of LLLT for treatment of OP are controversial.
Several studies have reported positive effects of LLLT on
ovariectomized induced OP (OVX-d) rats [18–20], whereas
others found no improvement in OVX-d and GIOP OP
models that underwent LLLT [21–23].
To the best of our knowledge, no study has been performed
that investigates the effects of pulsed wave (PW) LLLT on
stereological analysis of histological parameters and gene ex-
pression methods in the tibias of OVX-d and GIOP rats.
Paraclinical information such as BMD, biochemical markers,
histological parameters, and gene expression findings can as-
sist clinicians in determining the treatment of choice in pa-
tients with OP [24]. This study intends to evaluate the impacts
of PW LLLT on cortical bone in two experimental rat models
of OP.
We conducted a stereological analysis of histological pa-
rameters by measuring total bone volume, cortical bone vol-
ume, trabecular bone volume, and total bone marrow volume.
The numbers of osteocytes, osteoblasts, and osteoclasts were
counted by stereological techniques. TGF-β, IGF-I, BMP-2,
and type 1 collagen gene expressions were measured using the
real-time polymerase chain reaction (RT-PCR) method.
Materials and methods
Animals and study design
Both male and female Wistar rats were housed in standard rat
cages. Rats were maintained on a 12-h light/dark schedule and
provided water ad libitum. All procedures were approved by
the Medical Ethics Committee at Shahid Beheshti University
of Medical Sciences, Tehran, Iran (protocols no.: 1393-1-91-
1350 and 1392-1-115-1160). The rats’ body weights were
monitored weekly, and the volume of drugs administered
was calculated according to the most recent body weight. In
this study, OVX-d and GIOP rats tibias received PW LLLT
and alendronate. These rats subsequently underwent a stereo-
logical analysis of histological parameters and RT-PCR gene
expression evaluation methods. The healthy (H) group (group
5) comprised six normal rats which were used for the baseline
studies.
Sampling of the OVX-d and GIOP groups
We randomly divided 48 rats into eight groups of 6 rats per
group as follows: four groups of OVX-d rats and four groups
that received dexamethasone (GIOP). Ovariectomies were
performed while rats were under general anesthesia, via two
paravertebral skin incisions. The uterine tubes were ligated,
and after removal of the ovaries, we closed the incisions. Rats
received antibiotic therapy with ceftriaxone (50 mg/kg) imme-
diately before and 24 and 48 h after surgery [23]. All animals
were kept for 98 days after surgery in cages to allow for the
development of OP [25]. At the end of this period, the rats
were submitted to the following treatments: group 1 (OC)
comprised control rats with OP, group 2 (OA) were OVX-d
rats treated subcutaneously with 1 mg/kg alendronate (Alborz
Darou Co., Tehran, Iran), group 3 (OL) consisted of OVX-d
rats that received PW LLLT three times weekly (Table 1), and
group 4 (OAL) were OVX-d rats treated with PW LLLT and
concomitant administration of alendronate (1 mg/kg).
The remaining rats received a daily intramuscular (i.m.)
dose of dexamethasone (1 mg/kg; Alborz Darou Co.,
Tehran, Iran), administered 6 days per week for 5 weeks
[26]. After 5 weeks, dexamethasone-treated rats were
subdivided into four groups: group 6 (control) consisted of
OP rats treated with i.m. injections of vehicle (distilled water,
DC), group 7 (DA) or GIOP rats received subcutaneous
alendronate injections at a dose of 1 mg/kg (Alborz Darou
Co., Tehran, Iran) [27], group 8 (DL) consisted of GIOP rats
treated with PW LLLT (Table 1) three times per week, and
group 9 (DAL) consisted of GIOP rats treated with PW LLLT
and concomitant administration of 1 mg/kg/day alendronate.
In the laser groups, both tibias (four points each) were
completely radiated with the laser probe held vertically to
the bone from a distance of less than 10 mm. For 2 months,
the rats received PW LLLT. Rats received alendronate injec-
tions for 30 days. At 2 months after the beginning of the
treatments, all rats were sacrificed with an overdose of anes-
thesia. The right tibias were extracted for histological exami-
nation, and the left tibias were frozen at −80 °C for further RT-
PCR gene expression analyses.
Histological and stereological examinations
The bones were fixed in formalin saline and decalcified in
EDTA for a duration of 56 days, right after biomechanical
examination [23]. The primary volume V (primary) of the
Table 1 Specifications of the laser used
Parameters Dose and unit
Peak power output 75 W
Average power 1.08 mW
Power density 1.08 mW/cm2
Wave length 890 nm
Pulse frequency 80 Hz
Spot size 1 cm2
Pulsed duration 180 ns
Duration of exposure for each point 900 s
Energy density 0.972 J/cm2
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tibias was measured using the immersion method [28]. Then,
the tibia was embedded in paraffin blocks and cut longitudi-
nally into 5 and 25-μm-thick sections with a microtome. For a
microscopic descriptive analysis of each group, slides were
prepared by using hematoxylin and eosin (H&E) dyes. All
measurements were performed using a magnifying objective
(×4, ×40) (Fig. 1).
Stereological study
Measurement of bone volume
Using a projecting microscope, the live image of each tibial
bone section was evaluated. Following this procedure, eight to
ten sections were obtained and analyzed for each tibial bone.
The volumes (V) were calculated using the Cavalieri method.
Using the stereological software, a grid of points was
superimposed on the images. The volume of the tibial bone
was estimated by the following formula:
V boneð Þ ¼ ∑p a=p t
where Σp is the total points hitting the tibial bone sections, a /
p is the area associated with each point, and t is the distance
between the sampled sections [29, 31].
Estimation of the number of the bone cells
For estimation of numerical density and total number of the
bone cells, a dissector method was used. The specimens were
evaluated at ×40 magnification with high numerical aperture.
An image was captured and sent to the image analysis com-
puter. The focus plane was set at the surface of the specimen.
Then, a set of three unbiased measurement frames was
superimposed on the live image. At the same time, the
microcator measuring the optical distance through the speci-
men in the z-axis was zeroed. By gently moving the focus
down through the specimen, an approximately 0.5-mm-thin
focal plane made objects come into focus and disappear. Bone
cells falling in the measurement frames’ permitted areas were
counted as they came into focus until the microcator indicated
that the focal plane had traveled 10 μm through the specimen.
The numerical density of cells is obtained by
Nv ¼ ΣQ−= h a= f Σpð Þð Þ  t=BAð Þ
where ΣQ− is the number of the whole cells counted in all the
dissectors, h is the height of the optical dissector, a / f is the
area of the counting frame, Σp is the total number of the
counted frames, BA is the microtome block advance to cut
the block (25 μm), and t is the mean of the final section
thickness (20 μm),.To estimate the total number of the bone
cells, the following formula was used: N (bone cell) =Nv×V
(final) [30, 31].
RNA extraction
Frozen bones crushed by Chinese Haven were homogenized
in TRIzol (Invitrogen, USA) using a tissue laser instrument
(Qiagen, GmbH). The total RNAwas purified.
We added 200 μL of chloroform (Merck, Germany) to the
resultant TRIzol mixture; the samples were shaken vigorously
and incubated at room temperature for 5 min. Samples were
centrifuged at 10,000 RPM for 20 min at 4 °C. The separated,
colorless aqueous layer was mixed with 0.5 mL of
isopropanol. The samples were centrifuged again at 10,
000×g or 10,000 RPM for 20 min at 4 °C. The pellet was
resuspended in 1 mL ethanol and centrifuged at 12,
000 RPM for 20 min at 4 °C. The resultant pellet was dried
for 10 min at room temperature. Nuclease-free deionized wa-
ter (50 μL) was added, and the RNA concentration was esti-
mated by UV spectrophotometry at a 260 nm wavelength.
Purity was assessed by the A260/A280 ratio and
A260/A230 ratio.
Prior to reverse transcription, the sample was treated with
RNase-free DNase I (Takara Bio Inc., Japan) to remove any
contaminating DNA. For RT-PCR, 1 μg total RNA was re-
versely transcribed to complementary DNA (cDNA) with
oligo(dT) and random hexamer primers using 1 unit/mL M-
Fig. 1 Light micrograph of stereological examination of bony tissues (a)
and cells (b) (H&E)
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MLVreverse transcriptase (Invitrogen, CA, USA) at 95 °C for
15 min and 42 °C for 45 min.
RT-PCR
The expression of the candidate gene development was ana-
lyzed using quantitative RT-PCR with the SYBR® Green
Real-time PCR Master Mix (Takara Bio, Inc.). Table 2 shows
the oligonucleotide primers.
For each sample, three replicates for each target gene were
performed in a final volume of 20 μL that contained 10 μL of
2× SYBR® Green PCRMaster Mix, 1 μL cDNA, 2 μL of the
forward and reverse primers, and 7 μL of water. Thermo cy-
cling conditions were as follows: an initial denaturation at
95 °C for 2 min, followed by 35–40 cycles of 92 °C for
15 s, 60 °C annealing for 30 s, and a 72 °C extension for 45 s.
The specificity of the PCR amplification procedures was
checked with melting curves. Quantification of the relative
changes in gene expression was performed using the 2
−ΔΔCt method [32]. The mRNA levels of candidate genes
were normalized to the signal for 18s rRNA.
Statistical analysis
All data were expressed as mean ± standard errors of mean
(SEMs). Normal distribution of data was analyzed using the
Shapiro test. Parametric and nonparametric statistical methods
were used. The one-way analysis of variance (ANOVA) test
was used to compare changes among groups with normal
distribution of data, and the least significant difference
(LSD) test was used to identify differences. A p value of
≤0.05 was considered statistically significant. Nonparametric
methods were used for statistical analysis of the other groups.
These data were analyzed using the Kruskal-Wallis and
Mann-Whitney U tests. Differences were regarded as signifi-
cant if p<0.005 for analyses between groups 1 and 9. The
differences were also regarded as significant if p≤0.01 for
analyses between groups 1 and 5 and analyses between groups
5 and 9, respectively.
Results
We reported tibial weight changes in our previous paper [24].
Stereological analyses
The results of stereological analyses are shown in Figs. 2, 3, 4,
5, 6, 7, and 8.
In terms of total bone volume, the LSD test showed a
significant decrease in total bone volume in the OC group
compared to all groups with the exception of groups DC and
H (Fig. 2).
Significant increases existed in cortical bone volume
(mm3) in all study groups compared to the H group
(Mann-Whitney test), with p= 0.004 for the OC, OA, OL,
DC, DA, and DAL groups and p= 0.008 for the OAL and
DL groups. We observed a significant increase in osteo-
blasts in the DL group compared to the OC group
(p= 0.004; Fig. 3).
A significant decrease existed in trabecular bone volume
(mm3) in all study groups compared to the H group (Mann-
Whitney test), with p=0.004 for the OC, OA, OL, DC, DA,
and DAL groups and p=0.008 for the OAL and DL groups
(Fig. 4).
In terms of total bone marrow, the OC group showed
the lowest bone marrow volume among the studied
groups. Significant differences existed between the OC
group and the DC (Mann-Whitney test, p = 0.004), OA
(LSD test, p= 0.037), and OL (LSD test, p= 0.015) groups
(Fig. 5).
According to the LSD test, we observed significant de-
creases in osteocyte numbers in the OA (p = 0.05), OC
(p=0.008), OL (p=0.000), and OAL (p=0.019) groups com-
pared to the H group. The dexamethasone-treated rats showed
a significant increase in osteocyte numbers compared to the
OVX-d rats, as seen in Fig. 6.
According to theMann-Whitney test, there were significant
decreases in osteoblast numbers in the OA (p=0.008), OC
(p=0.004), and OL (p=0.004) groups compared to the H
group. The DA, DL, and DAL groups showed significant
Table 2 Primers of the selected
genes for quantitative real-time
PCR
Gene Gene ID Primer sequences
TGF-beta1 NM_021578.2 Forward: 5′ TAGCAACAATTCCTGGCGTTAC
Reverse: 5′ CCTGTATTCCGTCTCCTTGGTTC
IGF-I NM_001082478.1 Forward: 5′ GGAACATAAGGCACGCTGAAC
Reverse: 5′TGAGGAAGCAGGTAGATGGTGA
BMP-2 NM_017178.1 Forward: 5′ AGAAGCCAGGTGTCTCCAAGA
Reverse: 5′ CCACATCACTGAAGTCCACATACA
Type 1 collagen NM_053304.1 Forward: 5′ GGAGCAGCAAGAGCAAGGAG
Reverse: 5′ ACAGCAGGCGTAGGAAGGTC
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increases in osteoblasts compared to the OC, OA, and OL
groups. Figure 7 shows the significant differences.
The H group had the lowest number of osteoclasts among
the studied groups. The OC and DC groups showed signifi-
cant increases in osteoclast numbers compared to most other
groups (Fig. 8).
RT-PCR analysis
RT-PCR analysis results showed no significant differences in
mRNA gene expressions of TGF-β, IGF-I, BMP-2, and type
1 collagen among the studied groups (Fig. 9).
Discussion
In the current study, ten sections were sampled starting with a
random number between 1 and 10 and about eight to ten
sections in each animal were selected in a systematic random
manner.
After that, the microcator was attached to the stage of the
microscope to measure the z-axis traveling. At the same time,
the microcator measuring the optical distance through the
specimen in the z-axis was zeroed. The upper and lower guard
zones were used to avoid cutting artifacts that occurred at the
upper and lower surfaces of the tissue sections. The height of
the dissector was defined as the section thickness excluding
the 5-μm-thick guard zone at the upper and lower of each
section. Our study has shown the changes in the total volume
and total number of the bone cells in tibial diaphysis in two rat
models of experimental osteoporosis by using stereological
methods. The advantage of using stereological methods is
obtaining unbiased and precise estimations. The volume of
the trabecular bone and bone cells in the different structures
of the tibial diaphysis was estimated in advance.
The current study showed that both models of OVX-d and
GIOP experimental OP significantly decreased trabecular
bone volume, total bone marrow volume, and osteocyte and
osteoblast numbers compared to healthy rats. There were also
significant increases in cortical bone volume and osteoclast
numbers compared to the group of healthy rats. However,
the detrimental effects of an ovariectomy procedure on bone
were more serious than dexamethasone administration.
Our results have shown an increase in cortical bone pro-
duction. In post-menopausal osteoporotic women, an upregu-
lation of both bone formation and resorption occurs [13].
Likewise, OP in OVX-d rats is associated with increased turn-
over due to increased resorption that exceeds bone formation
[33]. This is attributed to the direct effect of estrogen on
Fig. 2 Mean ± SEM of the total bone volume (mm3) of the studied
groups compared by LSD test (*p < 0.05; **p < 0.01: ovariectomized
(OVX-d) control rats (OC), OVX-d rats treated with alendronate (OA),
OVX-d rats treated with LLLT (OL), OVX-d rats treated with LLLT and
alendronate (OAL), healthy rats (H), dexamethasone-treated control rats
(DC), dexamethasone-treated rats that received alendronate (DA),
dexamethasone-treated rats that received LLLT (DL), and
dexamethasone-treated rats that received alendronate and LLLT (DAL).
LSD test showed that there was a significant decrease in the total bone
volume of the OC group compared to all other groups except groups DC
and H
Fig. 3 Mean ± SEM of the
cortical bone volume (mm3) of
the studied groups compared by
Mann-Whitney test; **p< 0.01.
There was a significant increase
in the cortical bone volume in all
study groups compared to the
healthy group
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calcium absorption resulting in a direct influence on bone
turnover [34].
We have found a significant decrease in trabecular bone
volume in both the OVX-d and GIOP groups compared to
the healthy rats. Approximately 80 % of the total skeleton is
composed of cortical bone and the rest is comprised of trabec-
ular bone. Certain regions of the skeleton are rich in trabecular
bone. These areas include the vertebrae, femoral neck, and
distal radius [35]. After menopause, there is a rapid loss of
trabecular bone [36]. We have observed that GC changed the
trabecular bone’s properties and matrix composition. There
were also increased trabecular surface remodeling and trabec-
ular bone structure deterioration [36, 37].
In this study, cortical bone volume significantly increased
in all osteoporotic studied groups compared to the group of
healthy rats. However, the OP group had poor quality cortical
bone [38]. Both bone mass and matrix structure (e.g., collagen
mutations and minerals) contribute to bone strength [39]. The
current results have supported our recent study of OVX-d rats
and GIOP rat models. We reported no significant differences
between osteoporotic (OVX-d and GIOP) rats and healthy rats
in terms of high stress load [23].
OP is a disease that results in decreased bone density and
deterioration of bone structure [40]. Bisphosphonates are cur-
rently used as first-line therapeutic agents for OP.
Bisphosphonates inhibit bone resorption by selective adsorp-
tion to mineral surfaces and subsequent internalization by
bone-resorbing osteoclasts where they interfere with various
biochemical processes. Alendronate inhibits a key enzyme,
farnesyl pyrophosphate synthase, in the mevalonate pathway
and thereby prevents the biosynthesis of isoprenoid com-
pounds considered essential for post-translational modifica-
tion of small guanosine triphosphate (GTP)-binding proteins.
Both protein prenylation and function of these regulatory pro-
teins are impaired, leading to osteoclast dysfunction [41]. In
support, the current study results have shown that alendronate
Fig. 4 Mean ± SEM of the
trabecular bone volume (mm3) of
the studied groups compared by
Mann-Whitney test; **p< 0.01.
There was a significant decrease
in the trabecular bone volume in
all study groups compared to the
healthy group
Fig. 5 Mean ± SEM of the total
bone marrow volume (mm3) of
the studied groups compared by
Mann-Whitney test (for nine
groups) and LSD test (for OVX-d
groups); *p< 0.05; **p< 0.01.
The OC group showed the lowest
bone marrow volume among the
studied groups. There were
significant differences between
the OC group and the DC, OA,
and OL groups
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alone or in combination with PW LLLT significantly de-
creased osteoclast numbers compared to their control groups.
We observed that PW LLLT did not significantly reverse
the adverse effects observed in the tibias of OVX-d and GIOP
rats. These results agreed with previous findings [21]. Muniz
Renno et al. investigated the effects of CW LLLT on the fe-
murs from OVX-d rats that exercised. The rats underwent an
exercise program and laser irradiation for 48 h during 8 weeks.
The laser irradiation was performed using an aluminum galli-
um arsenide (AlGaAs) laser (830 nm, 100 W/cm2, 120 J/cm2,
Teralaser, DMC, São Carlos, SP, Brazil). There were greater
bone strength and physical properties in the exercised animals.
However, LLLT did not show any synergistic effect with ex-
ercise on osteoporotic rats. Medalha et al. studied the effects of
electrical stimulation and LLLTon bone loss in a rat model of
spinal cord injury in four groups of rats: standard control,
spinal cord-injured control (SC), spinal cord-injured rats treat-
edwith laser (SCL, GaAlAs, 830 nm, CW, 30mW/cm2, 250 J/
cm2), and spinal cord-injured rats subjected to electrical field
stimulation (SCE, 1.5 MHz, 1:4 duty cycles, 30 mW, 20 min).
The SC rats displayed a marked decrease in bone mass, bio-
mechanical properties, and morphometric parameters versus
the standard control group. The SCE rats had higher tibial
diaphysis areas and inner tibial diameters compared with the
Fig. 6 Mean ± SEM of osteocyte
numbers (×106) of the studied
groups compared by LSD test;
*p< 0.05; **p < 0.01;
***p< 0.001. There was a
significant decrease in osteocyte
number in the OA, OC, OL, and
OAL groups compared to the
healthy group. The
dexamethasone-treated rats
showed a significant increase in
osteocyte number compared to
the OVX-d rats
Fig. 7 Mean ± SEM of the
osteoblast numbers (×106) of the
studied groups compared by
Mann-Whitney test; **p< 0.01.
There was a significant decrease
in osteoblast number in the OA,
OC, and OL groups compared to
the healthy group. The DA, DL,
and DAL groups showed a
significant increase in osteoblast
number compared to the OC, OA,
and OL groups
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SC group. Results for the SCL group demonstrated a trend
toward the SC group results. They observed no increase in
either mechanical or densitometric parameters [22].
We observed that PW LLLT did not adequately reduce the
damage in ovariectomized rats with OP that received dexa-
methasone. The combination of alendronate and PW LLLT in
OVX-d rats and GIOP rats significantly decreased osteoclast
numbers in the osteoporotic tibias compared to the control
groups. The results of this study agreed with a study by
Diniz et al. [42]. These researchers investigated the effect of
CW LLLT in combination with bisphosphonate on osteopo-
rotic trabecular bone structure [42]. LLLT was performed
using a Ga-Al-As laser (830 nm, 50 mW, 4 J/cm2) on the neck
of the femur and the vertebral body. Surprisingly , in the as-
sociation between laser and alendronate, the trabecular bone
volume was significantly greater in the vertebras.
Muniz Renno et al. investigated the effects of an 830-nm
infrared LLLT on bone properties and bone strength of the
rats femurs after OVX. In their study, LLLT had a preventive
impact on bone loss in rats after OVX. The result of this study
contrasted the results reported by Renno et al. [20]. The reason
for this discrepancy might be attributed to differences in the
methodology. They initiated laser irradiation 1 day after OVX
at a dose of 120 J/cm2, and LLLTwas performed three times a
Fig. 8 Mean ± SEM of the
osteoclast numbers (×103) of the
studied groups compared by
Mann-Whitney test; **p< 0.01.
The healthy group showed the
lowest number of osteoclasts
among the studied groups. The
OC and DC groups showed
significant increases in osteoblast
number compared to most other
groups
Fig. 9 Mean ± SEM of mRNA
levels of TGF-beta, IGF-I, BMP-
2, and type 1 collagen of studied
groups compared by Mann-
Whitney test. Real-time PCR
analysis revealed that there were
no significant differences of
mRNA gene expression of TGF-
beta, IGF-I, BMP-2, and type 1
collagen among the studied
groups
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week for 2 months after which the femurs were submitted to a
biomechanical test and evaluation of physical properties [20].
Recently, a number of studies have investigated the effects
of LLLT on the repair process of osteoporotic fractures. Some
authors reported that laser irradiation alone accelerated the
initial phase of the repair process [43], inhibited the inflam-
matory process, and induced cell proliferation [44]. Scalize
et al. reported that LLLT (20 and 30 J/cm2) improved bone
formation in osteoporotic rats. They observed significantly
more new bone formation in the groups that received 20 and
30 J/cm2 compared to the control groups. These researchers
used stereological parameters to evaluate the repair process in
osteoporotic fractures [45]. The effects of 50 mJ/cm2 [43] and
133 J/cm2 [44] on the repair process of osteoporotic fractures
were evaluated by histological analysis [43, 44]. Other studies
that focused on the use of bone scaffolds in addition to
morphometrical and biomechanical evaluating methods re-
ported conflicting results. Bossini et al. reported that LLLT
irradiation in combination with Biosilicate® led to improve-
ments in bone repair because it increased bone formation,
deposition of collagen, and angiogenesis [46]. Fangel et al.
investigated the effects of Biosilicate® and LLLT (60 J/cm2)
on bone fracture consolidation in osteoporotic rats. They ob-
served that the combination of LLLT with Biosilicate® im-
proved bone formation, bone repair, and indentation values,
as a biomechanical test [47]. Fangel et al., in another study,
investigated the effects of LLLT and Biosilicate® on the bio-
mechanical properties of the bone callus in osteoporotic rats.
They concluded that Biosilicate® alone or in association with
LLLT improved the biomechanical properties of the tibial
bone callus in these rats [48].
Three hypotheses that attempt to explain the lack of a stim-
ulatory effect of PW LLLT on osteoporotic rats can be sug-
gested. First, this finding could be due to the deep, systemic
effects of OP on bone. It seems possible that the OVX-d and
GIOP models used in the current study were so profound that
the osteoporotic bone tissue was not able to respond properly
to any stimulation (PW LLLT or alendronate). Another possi-
bility could be the PW LLLT parameters employed in this
study. The applied dose was selected in accordance with two
studies which demonstrated that an 890-nm infrared laser at
0.972 J/cm2 increased bone strength in healthy rats [23, 49].
Finally, the use of LLLT has been shown to rely to a large
extent on the local effects of lights on the tissues [50, 51];
however, OP is a systemic disease.
Conclusion
The OVX-d and GIOP animal OP models used in this study
had negative effects on bone tissue. Alendronate significantly
decreased osteoclast numbers in osteoporotic rats. Concurrent
treatments of PW LLLT and alendronate produced the same
effect on osteoporotic bone. Since the PW LLLT has osteo-
genic effects, different parameters should be investigated to
verify whether an appropriate PW LLLT protocol in combi-
nation with a proper(s) anti-osteoporotic agent(s) might re-
verse the detrimental effects of OP.
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